International sales boost SonoSite's 2003 results

Growth of its international operations and sales of its new Titan hand-carried ultrasound system powered SonoSite Inc. to greater revenues in 2003.

Revenues advanced 16 percent to $84.8 million, compared with $73 million in 2002. The company also reduced its net loss to $1.8 million, compared with a net loss of $7.7 million in 2002.

SonoSite introduced Titan in the middle of 2002 and accounted for 45 percent of the company's worldwide revenues in the fourth quarter. SonoSite also estimated its total installed base at 14,000 systems worldwide.

The company added that it is targeting increased revenues of approximately 25 percent this year.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup